▶ 調査レポート

世界のイソフェンインスリン注射市場インサイト・予測(~2027年)

• 英文タイトル:Global Isophane Insulin Injection Market Insights and Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。世界のイソフェンインスリン注射市場インサイト・予測(~2027年) / Global Isophane Insulin Injection Market Insights and Forecast to 2027 / QY2108PAL3980資料のイメージです。• レポートコード:QY2108PAL3980
• 出版社/出版日:QYResearch / 2021年8月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、85ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料はイソフェンインスリン注射の世界市場の現状について調査・分析し、2027年までの市場を予測しました。イソフェンインスリン注射の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(3ml / 300ユニット、10ml / 400ユニット)、用途別市場規模(軽度糖尿病患者、重度糖尿病患者)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・イソフェンインスリン注射の世界市場概要
・メーカー別の競争状況、市場シェア
・イソフェンインスリン注射の種類別市場規模:3ml / 300ユニット、10ml / 400ユニット
・イソフェンインスリン注射の用途別市場規模:軽度糖尿病患者、重度糖尿病患者
・北米のイソフェンインスリン注射市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパのイソフェンインスリン注射市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアのイソフェンインスリン注射市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米のイソフェンインスリン注射市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカのイソフェンインスリン注射市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:Ranbaxy Laboratories Ltd.、Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd、Novo Nordisk Pharma lndia Ltd.
・イソフェンインスリン注射のバリューチェーン・販売チャネル分析
・イソフェンインスリン注射の世界市場動向

Isophane Insulin Injection is used in the treatment of moderate and mild diabetes patients. Severe cases must be combined with regular insulin to reduce the number of daily insulin injections and control nighttime hyperglycemia. This drug is classified under the Diabetes and other drug categories.

Market Analysis and Insights: Global Isophane Insulin Injection Market
The global Isophane Insulin Injection market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Isophane Insulin Injection Scope and Segment
Isophane Insulin Injection market is segmented by Dosage, and by Application. Players, stakeholders, and other participants in the global Isophane Insulin Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Dosage and by Application for the period 2016-2027.

Segment by Dosage
3ml/300Units
10ml/400Units

Segment by Application
People With Mild Diabetes
Patients With Severe Diabetes

By Company
Ranbaxy Laboratories Ltd.
Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd
Novo Nordisk Pharma lndia Ltd.

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Isophane Insulin Injection Product Introduction
1.2 Market by Dosage
1.2.1 Global Isophane Insulin Injection Market Size Growth Rate by Dosage
1.2.2 3ml/300Units
1.2.3 10ml/400Units
1.3 Market by Application
1.3.1 Global Isophane Insulin Injection Market Size Growth Rate by Application
1.3.2 People With Mild Diabetes
1.3.3 Patients With Severe Diabetes
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Isophane Insulin Injection Sales Estimates and Forecasts 2016-2027
2.2 Global Isophane Insulin Injection Revenue Estimates and Forecasts 2016-2027
2.3 Global Isophane Insulin Injection Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Isophane Insulin Injection Regions by Sales
2.4.1 Global Top Isophane Insulin Injection Regions by Sales (2016-2021)
2.4.2 Global Top Isophane Insulin Injection Regions by Sales (2022-2027)
2.5 Global Top Isophane Insulin Injection Regions by Revenue
2.5.1 Global Top Isophane Insulin Injection Regions by Revenue (2016-2021)
2.5.2 Global Top Isophane Insulin Injection Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Isophane Insulin Injection Sales by Manufacturers
3.1.1 Global Top Isophane Insulin Injection Manufacturers by Sales (2016-2021)
3.1.2 Global Top Isophane Insulin Injection Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Isophane Insulin Injection Sales in 2020
3.2 Global Isophane Insulin Injection Revenue by Manufacturers
3.2.1 Global Top Isophane Insulin Injection Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Isophane Insulin Injection Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Isophane Insulin Injection Revenue in 2020
3.3 Global Isophane Insulin Injection Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Isophane Insulin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Isophane Insulin Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Isophane Insulin Injection Sales by Dosage
4.1.1 Global Isophane Insulin Injection Historical Sales by Dosage (2016-2021)
4.1.2 Global Isophane Insulin Injection Forecasted Sales by Dosage (2022-2027)
4.1.3 Global Isophane Insulin Injection Sales Market Share by Dosage (2016-2027)
4.2 Global Isophane Insulin Injection Revenue by Dosage
4.2.1 Global Isophane Insulin Injection Historical Revenue by Dosage (2016-2021)
4.2.2 Global Isophane Insulin Injection Forecasted Revenue by Dosage (2022-2027)
4.2.3 Global Isophane Insulin Injection Revenue Market Share by Dosage (2016-2027)
4.3 Global Isophane Insulin Injection Price by Dosage
4.3.1 Global Isophane Insulin Injection Price by Dosage (2016-2021)
4.3.2 Global Isophane Insulin Injection Price Forecast by Dosage (2022-2027)

5 Market Size by Application
5.1 Global Isophane Insulin Injection Sales by Application
5.1.1 Global Isophane Insulin Injection Historical Sales by Application (2016-2021)
5.1.2 Global Isophane Insulin Injection Forecasted Sales by Application (2022-2027)
5.1.3 Global Isophane Insulin Injection Sales Market Share by Application (2016-2027)
5.2 Global Isophane Insulin Injection Revenue by Application
5.2.1 Global Isophane Insulin Injection Historical Revenue by Application (2016-2021)
5.2.2 Global Isophane Insulin Injection Forecasted Revenue by Application (2022-2027)
5.2.3 Global Isophane Insulin Injection Revenue Market Share by Application (2016-2027)
5.3 Global Isophane Insulin Injection Price by Application
5.3.1 Global Isophane Insulin Injection Price by Application (2016-2021)
5.3.2 Global Isophane Insulin Injection Price Forecast by Application (2022-2027)

6 North America
6.1 North America Isophane Insulin Injection Market Size by Dosage
6.1.1 North America Isophane Insulin Injection Sales by Dosage (2016-2027)
6.1.2 North America Isophane Insulin Injection Revenue by Dosage (2016-2027)
6.2 North America Isophane Insulin Injection Market Size by Application
6.2.1 North America Isophane Insulin Injection Sales by Application (2016-2027)
6.2.2 North America Isophane Insulin Injection Revenue by Application (2016-2027)
6.3 North America Isophane Insulin Injection Market Size by Country
6.3.1 North America Isophane Insulin Injection Sales by Country (2016-2027)
6.3.2 North America Isophane Insulin Injection Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Isophane Insulin Injection Market Size by Dosage
7.1.1 Europe Isophane Insulin Injection Sales by Dosage (2016-2027)
7.1.2 Europe Isophane Insulin Injection Revenue by Dosage (2016-2027)
7.2 Europe Isophane Insulin Injection Market Size by Application
7.2.1 Europe Isophane Insulin Injection Sales by Application (2016-2027)
7.2.2 Europe Isophane Insulin Injection Revenue by Application (2016-2027)
7.3 Europe Isophane Insulin Injection Market Size by Country
7.3.1 Europe Isophane Insulin Injection Sales by Country (2016-2027)
7.3.2 Europe Isophane Insulin Injection Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Isophane Insulin Injection Market Size by Dosage
8.1.1 Asia Pacific Isophane Insulin Injection Sales by Dosage (2016-2027)
8.1.2 Asia Pacific Isophane Insulin Injection Revenue by Dosage (2016-2027)
8.2 Asia Pacific Isophane Insulin Injection Market Size by Application
8.2.1 Asia Pacific Isophane Insulin Injection Sales by Application (2016-2027)
8.2.2 Asia Pacific Isophane Insulin Injection Revenue by Application (2016-2027)
8.3 Asia Pacific Isophane Insulin Injection Market Size by Region
8.3.1 Asia Pacific Isophane Insulin Injection Sales by Region (2016-2027)
8.3.2 Asia Pacific Isophane Insulin Injection Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Isophane Insulin Injection Market Size by Dosage
9.1.1 Latin America Isophane Insulin Injection Sales by Dosage (2016-2027)
9.1.2 Latin America Isophane Insulin Injection Revenue by Dosage (2016-2027)
9.2 Latin America Isophane Insulin Injection Market Size by Application
9.2.1 Latin America Isophane Insulin Injection Sales by Application (2016-2027)
9.2.2 Latin America Isophane Insulin Injection Revenue by Application (2016-2027)
9.3 Latin America Isophane Insulin Injection Market Size by Country
9.3.1 Latin America Isophane Insulin Injection Sales by Country (2016-2027)
9.3.2 Latin America Isophane Insulin Injection Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia

10 Middle East and Africa
10.1 Middle East and Africa Isophane Insulin Injection Market Size by Dosage
10.1.1 Middle East and Africa Isophane Insulin Injection Sales by Dosage (2016-2027)
10.1.2 Middle East and Africa Isophane Insulin Injection Revenue by Dosage (2016-2027)
10.2 Middle East and Africa Isophane Insulin Injection Market Size by Application
10.2.1 Middle East and Africa Isophane Insulin Injection Sales by Application (2016-2027)
10.2.2 Middle East and Africa Isophane Insulin Injection Revenue by Application (2016-2027)
10.3 Middle East and Africa Isophane Insulin Injection Market Size by Country
10.3.1 Middle East and Africa Isophane Insulin Injection Sales by Country (2016-2027)
10.3.2 Middle East and Africa Isophane Insulin Injection Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Ranbaxy Laboratories Ltd.
11.1.1 Ranbaxy Laboratories Ltd. Corporation Information
11.1.2 Ranbaxy Laboratories Ltd. Overview
11.1.3 Ranbaxy Laboratories Ltd. Isophane Insulin Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Ranbaxy Laboratories Ltd. Isophane Insulin Injection Product Description
11.1.5 Ranbaxy Laboratories Ltd. Recent Developments
11.2 Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd
11.2.1 Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Corporation Information
11.2.2 Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Overview
11.2.3 Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Isophane Insulin Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Isophane Insulin Injection Product Description
11.2.5 Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Recent Developments
11.3 Novo Nordisk Pharma lndia Ltd.
11.3.1 Novo Nordisk Pharma lndia Ltd. Corporation Information
11.3.2 Novo Nordisk Pharma lndia Ltd. Overview
11.3.3 Novo Nordisk Pharma lndia Ltd. Isophane Insulin Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Novo Nordisk Pharma lndia Ltd. Isophane Insulin Injection Product Description
11.3.5 Novo Nordisk Pharma lndia Ltd. Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Isophane Insulin Injection Value Chain Analysis
12.2 Isophane Insulin Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Isophane Insulin Injection Production Mode & Process
12.4 Isophane Insulin Injection Sales and Marketing
12.4.1 Isophane Insulin Injection Sales Channels
12.4.2 Isophane Insulin Injection Distributors
12.5 Isophane Insulin Injection Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Isophane Insulin Injection Industry Trends
13.2 Isophane Insulin Injection Market Drivers
13.3 Isophane Insulin Injection Market Challenges
13.4 Isophane Insulin Injection Market Restraints

14 Key Findings in The Global Isophane Insulin Injection Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Isophane Insulin Injection Market Size Growth Rate by Dosage, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 3ml/300Units
Table 3. Major Manufacturers of 10ml/400Units
Table 4. Global Isophane Insulin Injection Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Isophane Insulin Injection Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Isophane Insulin Injection Sales by Region (2016-2021) & (K Doses)
Table 7. Global Isophane Insulin Injection Sales Market Share by Region (2016-2021)
Table 8. Global Isophane Insulin Injection Sales by Region (2022-2027) & (K Doses)
Table 9. Global Isophane Insulin Injection Sales Market Share by Region (2022-2027)
Table 10. Global Isophane Insulin Injection Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Isophane Insulin Injection Revenue Market Share by Region (2016-2021)
Table 12. Global Isophane Insulin Injection Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Isophane Insulin Injection Revenue Market Share by Region (2022-2027)
Table 14. Global Isophane Insulin Injection Sales by Manufacturers (2016-2021) & (K Doses)
Table 15. Global Isophane Insulin Injection Sales Share by Manufacturers (2016-2021)
Table 16. Global Isophane Insulin Injection Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Isophane Insulin Injection Revenue Share by Manufacturers (2016-2021)
Table 18. Isophane Insulin Injection Price by Manufacturers 2016-2021 (US$/Dose)
Table 19. Global Isophane Insulin Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Isophane Insulin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isophane Insulin Injection as of 2020)
Table 21. Isophane Insulin Injection Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Isophane Insulin Injection Product Offered
Table 23. Date of Manufacturers Enter into Isophane Insulin Injection Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Isophane Insulin Injection Sales by Dosage (2016-2021) & (K Doses)
Table 26. Global Isophane Insulin Injection Sales by Dosage (2022-2027) & (K Doses)
Table 27. Global Isophane Insulin Injection Sales Share by Dosage (2016-2021)
Table 28. Global Isophane Insulin Injection Sales Share by Dosage (2022-2027)
Table 29. Global Isophane Insulin Injection Revenue by Dosage (2016-2021) & (US$ Million)
Table 30. Global Isophane Insulin Injection Revenue by Dosage (2022-2027) & (US$ Million)
Table 31. Global Isophane Insulin Injection Revenue Share by Dosage (2016-2021)
Table 32. Global Isophane Insulin Injection Revenue Share by Dosage (2022-2027)
Table 33. Isophane Insulin Injection Price by Dosage (2016-2021) & (US$/Dose)
Table 34. Global Isophane Insulin Injection Price Forecast by Dosage (2022-2027) & (US$/Dose)
Table 35. Global Isophane Insulin Injection Sales by Application (2016-2021) & (K Doses)
Table 36. Global Isophane Insulin Injection Sales by Application (2022-2027) & (K Doses)
Table 37. Global Isophane Insulin Injection Sales Share by Application (2016-2021)
Table 38. Global Isophane Insulin Injection Sales Share by Application (2022-2027)
Table 39. Global Isophane Insulin Injection Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Isophane Insulin Injection Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Isophane Insulin Injection Revenue Share by Application (2016-2021)
Table 42. Global Isophane Insulin Injection Revenue Share by Application (2022-2027)
Table 43. Isophane Insulin Injection Price by Application (2016-2021) & (US$/Dose)
Table 44. Global Isophane Insulin Injection Price Forecast by Application (2022-2027) & (US$/Dose)
Table 45. North America Isophane Insulin Injection Sales by Dosage (2016-2021) & (K Doses)
Table 46. North America Isophane Insulin Injection Sales by Dosage (2022-2027) & (K Doses)
Table 47. North America Isophane Insulin Injection Revenue by Dosage (2016-2021) & (US$ Million)
Table 48. North America Isophane Insulin Injection Revenue by Dosage (2022-2027) & (US$ Million)
Table 49. North America Isophane Insulin Injection Sales by Application (2016-2021) & (K Doses)
Table 50. North America Isophane Insulin Injection Sales by Application (2022-2027) & (K Doses)
Table 51. North America Isophane Insulin Injection Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Isophane Insulin Injection Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Isophane Insulin Injection Sales by Country (2016-2021) & (K Doses)
Table 54. North America Isophane Insulin Injection Sales by Country (2022-2027) & (K Doses)
Table 55. North America Isophane Insulin Injection Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Isophane Insulin Injection Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Isophane Insulin Injection Sales by Dosage (2016-2021) & (K Doses)
Table 58. Europe Isophane Insulin Injection Sales by Dosage (2022-2027) & (K Doses)
Table 59. Europe Isophane Insulin Injection Revenue by Dosage (2016-2021) & (US$ Million)
Table 60. Europe Isophane Insulin Injection Revenue by Dosage (2022-2027) & (US$ Million)
Table 61. Europe Isophane Insulin Injection Sales by Application (2016-2021) & (K Doses)
Table 62. Europe Isophane Insulin Injection Sales by Application (2022-2027) & (K Doses)
Table 63. Europe Isophane Insulin Injection Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Isophane Insulin Injection Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Isophane Insulin Injection Sales by Country (2016-2021) & (K Doses)
Table 66. Europe Isophane Insulin Injection Sales by Country (2022-2027) & (K Doses)
Table 67. Europe Isophane Insulin Injection Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Isophane Insulin Injection Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Isophane Insulin Injection Sales by Dosage (2016-2021) & (K Doses)
Table 70. Asia Pacific Isophane Insulin Injection Sales by Dosage (2022-2027) & (K Doses)
Table 71. Asia Pacific Isophane Insulin Injection Revenue by Dosage (2016-2021) & (US$ Million)
Table 72. Asia Pacific Isophane Insulin Injection Revenue by Dosage (2022-2027) & (US$ Million)
Table 73. Asia Pacific Isophane Insulin Injection Sales by Application (2016-2021) & (K Doses)
Table 74. Asia Pacific Isophane Insulin Injection Sales by Application (2022-2027) & (K Doses)
Table 75. Asia Pacific Isophane Insulin Injection Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Isophane Insulin Injection Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Isophane Insulin Injection Sales by Region (2016-2021) & (K Doses)
Table 78. Asia Pacific Isophane Insulin Injection Sales by Region (2022-2027) & (K Doses)
Table 79. Asia Pacific Isophane Insulin Injection Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Isophane Insulin Injection Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Isophane Insulin Injection Sales by Dosage (2016-2021) & (K Doses)
Table 82. Latin America Isophane Insulin Injection Sales by Dosage (2022-2027) & (K Doses)
Table 83. Latin America Isophane Insulin Injection Revenue by Dosage (2016-2021) & (US$ Million)
Table 84. Latin America Isophane Insulin Injection Revenue by Dosage (2022-2027) & (US$ Million)
Table 85. Latin America Isophane Insulin Injection Sales by Application (2016-2021) & (K Doses)
Table 86. Latin America Isophane Insulin Injection Sales by Application (2022-2027) & (K Doses)
Table 87. Latin America Isophane Insulin Injection Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Isophane Insulin Injection Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Isophane Insulin Injection Sales by Country (2016-2021) & (K Doses)
Table 90. Latin America Isophane Insulin Injection Sales by Country (2022-2027) & (K Doses)
Table 91. Latin America Isophane Insulin Injection Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Isophane Insulin Injection Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Isophane Insulin Injection Sales by Dosage (2016-2021) & (K Doses)
Table 94. Middle East and Africa Isophane Insulin Injection Sales by Dosage (2022-2027) & (K Doses)
Table 95. Middle East and Africa Isophane Insulin Injection Revenue by Dosage (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Isophane Insulin Injection Revenue by Dosage (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Isophane Insulin Injection Sales by Application (2016-2021) & (K Doses)
Table 98. Middle East and Africa Isophane Insulin Injection Sales by Application (2022-2027) & (K Doses)
Table 99. Middle East and Africa Isophane Insulin Injection Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Isophane Insulin Injection Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Isophane Insulin Injection Sales by Country (2016-2021) & (K Doses)
Table 102. Middle East and Africa Isophane Insulin Injection Sales by Country (2022-2027) & (K Doses)
Table 103. Middle East and Africa Isophane Insulin Injection Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Isophane Insulin Injection Revenue by Country (2022-2027) & (US$ Million)
Table 105. Ranbaxy Laboratories Ltd. Corporation Information
Table 106. Ranbaxy Laboratories Ltd. Description and Major Businesses
Table 107. Ranbaxy Laboratories Ltd. Isophane Insulin Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 108. Ranbaxy Laboratories Ltd. Isophane Insulin Injection Product
Table 109. Ranbaxy Laboratories Ltd. Recent Developments
Table 110. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Corporation Information
Table 111. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Description and Major Businesses
Table 112. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Isophane Insulin Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 113. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Isophane Insulin Injection Product
Table 114. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Recent Developments
Table 115. Novo Nordisk Pharma lndia Ltd. Corporation Information
Table 116. Novo Nordisk Pharma lndia Ltd. Description and Major Businesses
Table 117. Novo Nordisk Pharma lndia Ltd. Isophane Insulin Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 118. Novo Nordisk Pharma lndia Ltd. Isophane Insulin Injection Product
Table 119. Novo Nordisk Pharma lndia Ltd. Recent Developments
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Isophane Insulin Injection Distributors List
Table 123. Isophane Insulin Injection Customers List
Table 124. Isophane Insulin Injection Market Trends
Table 125. Isophane Insulin Injection Market Drivers
Table 126. Isophane Insulin Injection Market Challenges
Table 127. Isophane Insulin Injection Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Isophane Insulin Injection Product Picture
Figure 2. Global Isophane Insulin Injection Market Share by Dosage in 2020 & 2027
Figure 3. 3ml/300Units Product Picture
Figure 4. 10ml/400Units Product Picture
Figure 5. Global Isophane Insulin Injection Market Share by Application in 2020 & 2027
Figure 6. People With Mild Diabetes
Figure 7. Patients With Severe Diabetes
Figure 8. Isophane Insulin Injection Report Years Considered
Figure 9. Global Isophane Insulin Injection Sales 2016-2027 (K Doses)
Figure 10. Global Isophane Insulin Injection Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Isophane Insulin Injection Revenue 2016-2027 (US$ Million)
Figure 12. Global Isophane Insulin Injection Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 13. Global Isophane Insulin Injection Sales Market Share by Region (2016-2021)
Figure 14. Global Isophane Insulin Injection Sales Market Share by Region (2022-2027)
Figure 15. North America Isophane Insulin Injection Sales YoY (2016-2027) & (K Doses)
Figure 16. North America Isophane Insulin Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 17. Europe Isophane Insulin Injection Sales YoY (2016-2027) & (K Doses)
Figure 18. Europe Isophane Insulin Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Asia-Pacific Isophane Insulin Injection Sales YoY (2016-2027) & (K Doses)
Figure 20. Asia-Pacific Isophane Insulin Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Latin America Isophane Insulin Injection Sales YoY (2016-2027) & (K Doses)
Figure 22. Latin America Isophane Insulin Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Middle East & Africa Isophane Insulin Injection Sales YoY (2016-2027) & (K Doses)
Figure 24. Middle East & Africa Isophane Insulin Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 25. The Top 10 and Top 5 Players Market Share by Isophane Insulin Injection Sales in 2020
Figure 26. The Top 10 and Top 5 Players Market Share by Isophane Insulin Injection Revenue in 2020
Figure 27. Isophane Insulin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 28. Global Isophane Insulin Injection Sales Market Share by Dosage (2016-2027)
Figure 29. Global Isophane Insulin Injection Revenue Market Share by Dosage (2016-2027)
Figure 30. Global Isophane Insulin Injection Sales Market Share by Application (2016-2027)
Figure 31. Global Isophane Insulin Injection Revenue Market Share by Application (2016-2027)
Figure 32. North America Isophane Insulin Injection Sales Market Share by Dosage (2016-2027)
Figure 33. North America Isophane Insulin Injection Revenue Market Share by Dosage (2016-2027)
Figure 34. North America Isophane Insulin Injection Sales Market Share by Application (2016-2027)
Figure 35. North America Isophane Insulin Injection Revenue Market Share by Application (2016-2027)
Figure 36. North America Isophane Insulin Injection Sales Share by Country (2016-2027)
Figure 37. North America Isophane Insulin Injection Revenue Share by Country (2016-2027)
Figure 38. United States Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 39. Canada Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 40. Europe Isophane Insulin Injection Sales Market Share by Dosage (2016-2027)
Figure 41. Europe Isophane Insulin Injection Revenue Market Share by Dosage (2016-2027)
Figure 42. Europe Isophane Insulin Injection Sales Market Share by Application (2016-2027)
Figure 43. Europe Isophane Insulin Injection Revenue Market Share by Application (2016-2027)
Figure 44. Europe Isophane Insulin Injection Sales Share by Country (2016-2027)
Figure 45. Europe Isophane Insulin Injection Revenue Share by Country (2016-2027)
Figure 46. Germany Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 47. France Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 48. U.K. Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 49. Italy Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 50. Russia Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 51. Asia Pacific Isophane Insulin Injection Sales Market Share by Dosage (2016-2027)
Figure 52. Asia Pacific Isophane Insulin Injection Revenue Market Share by Dosage (2016-2027)
Figure 53. Asia Pacific Isophane Insulin Injection Sales Market Share by Application (2016-2027)
Figure 54. Asia Pacific Isophane Insulin Injection Revenue Market Share by Application (2016-2027)
Figure 55. Asia Pacific Isophane Insulin Injection Sales Share by Region (2016-2027)
Figure 56. Asia Pacific Isophane Insulin Injection Revenue Share by Region (2016-2027)
Figure 57. China Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 58. Japan Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 59. South Korea Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 60. India Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 61. Australia Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 62. China Taiwan Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 63. Indonesia Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 64. Thailand Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 65. Malaysia Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 66. Latin America Isophane Insulin Injection Sales Market Share by Dosage (2016-2027)
Figure 67. Latin America Isophane Insulin Injection Revenue Market Share by Dosage (2016-2027)
Figure 68. Latin America Isophane Insulin Injection Sales Market Share by Application (2016-2027)
Figure 69. Latin America Isophane Insulin Injection Revenue Market Share by Application (2016-2027)
Figure 70. Latin America Isophane Insulin Injection Sales Share by Country (2016-2027)
Figure 71. Latin America Isophane Insulin Injection Revenue Share by Country (2016-2027)
Figure 72. Mexico Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 73. Brazil Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 74. Argentina Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 75. Colombia Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 76. Middle East and Africa Isophane Insulin Injection Sales Market Share by Dosage (2016-2027)
Figure 77. Middle East and Africa Isophane Insulin Injection Revenue Market Share by Dosage (2016-2027)
Figure 78. Middle East and Africa Isophane Insulin Injection Sales Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Isophane Insulin Injection Revenue Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Isophane Insulin Injection Sales Share by Country (2016-2027)
Figure 81. Middle East and Africa Isophane Insulin Injection Revenue Share by Country (2016-2027)
Figure 82. Turkey Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 83. Saudi Arabia Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 84. UAE Isophane Insulin Injection Revenue (2016-2027) & (US$ Million)
Figure 85. Isophane Insulin Injection Value Chain
Figure 86. Isophane Insulin Injection Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed